Justin Killebrew

Justin Killebrew has an extensive work experience in the field of immuno-oncology discovery. Justin is currently working at Bonum Therapeutics as a Senior Director of Immuno-Oncology Discovery since September 2022. Prior to that, they worked at Good Therapeutics, Inc. as a Senior Director of Immuno-Oncology Discovery from June 2021 to September 2022, and as a Director of Immuno-Oncology Discovery from November 2018 to June 2021. Before joining Good Therapeutics, Inc., they held positions at Silverback Therapeutics, where they served as a Director of Discovery Biology from October 2017 to November 2018, and as a Senior Scientist II of Discovery Biology from October 2016 to October 2017. Justin's career also includes working at Bristol-Myers Squibb, where they worked as a Senior Scientist of Immuno-Oncology Discovery from June 2015 to July 2016, and as a Scientist II of Immuno-Oncology Discovery from March 2012 to June 2015.

Justin Killebrew holds a Ph.D. in Immunology from the University of Washington - School of Medicine. Prior to that, they earned a B.S. in Microbiology from Colorado State University. No specific start or end years are provided for either of these degrees.